Minoxidil Tablets Articles
Japan stock market week to March 2, 2009
9 March 2009
Japan stock market week to Nov 24, 2008
24 November 2008
Japan stock market week to August 25, 2008
1 September 2008
Japan stock market week to Oct 16, 2006
23 October 2006
Japan stock market week to March 27, 2006
3 April 2006
Japan stock market week to February 21
28 February 2005
Tokyo pharma stocks - week to Sept 29
13 October 2003
Tokyo pharma stocks - 2 weeks to Dec 30
6 January 2003
Taisho Pharma profit takes a 10.7% fall
12 November 2001
Japan's Taisho and Tanabe joining forces in $2.94 billion merger
19 September 2001
Stock Commentary - Tokyo
31 May 2001
Taisho to test RiUP in women
1 February 2001
Stock Commentary - Tokyo
7 December 2000
Stock Commentary Tokyo
21 September 2000
Stock Commentary Tokyo
31 August 2000
Slight slip in Tokyo pharma stocks
22 August 2000
Stock Commentary Tokyo
25 May 2000
Taisho profits forecast to rise 40%
17 March 2000
Australian OTC sales rose 8% in 1999
26 January 2000
Stock Commentary Tokyo
6 January 2000
Taisho not too worried about RiUP warnings
14 December 1999
RiUP side effects "unrelated to external use," says Taisho
9 December 1999
Stock Commentary Tokyo
2 December 1999
Stock Commentary Tokyo
25 November 1999
Taisho to suffer from bad RiUP publicity?
24 November 1999
Stock Commentary Tokyo
18 November 1999
Stock Commentary Tokyo
4 November 1999
Stock Commentary Tokyo
28 October 1999
Stock Commentary Tokyo
14 October 1999
Banyu forecasts strong profits for 2004
11 October 1999
Stock Commentary Tokyo
5 August 1999
Stock Commentary Tokyo
29 July 1999
Stock Commentary Tokyo
15 July 1999
OTC ads "beat DTC for product recall"
14 July 1999
Stock Commentary Tokyo
8 July 1999
Stock Commentary Tokyo
1 July 1999
Stock Commentary Tokyo
3 June 1999
Stock Commentary Tokyo
27 May 1999
Stock Commentary Tokyo
20 May 1999
Taisho launches minoxidil in Japan
12 May 1999
-Taisho's Rogaine approved in Japan
4 March 1999
Stock Commentary Tokyo
4 March 1999
Stock Commentary Tokyo
14 January 1999
Stock Commentary Tokyo
7 January 1999
US 2nd-Qtr Rx DTC Spending Rises 25%
6 November 1998
B-MS Licenses Unilever Hair Research
8 October 1998
New Assistant Brand Manager For Regaine
20 August 1998
Pharmacia & Upjohn Turnaround Continuing
31 July 1998
Merck & Co's Propecia "Not Effective In Women"
14 May 1998
Unapproved Drugs Imported Into Japan
8 May 1998
P&U Sales Up, Says Turnaround Is On Track
30 April 1998
Merck In $60 Million DTC Ads For Propecia
30 April 1998
Pfizer's Impotence Pill Wins FDA Clearance
31 March 1998
Long-Term Efficacy With Merck & Co's Proscar
5 March 1998
Capitalizing On Hair Loss Market In The UK
23 February 1998
Impact Of Propecia On Merck & Co Assessed
28 January 1998
UK Planning Product Status Switches
21 January 1998
Propecia Approved In USA For Male Pattern Baldness
12 January 1998
New Products In 1998; A Look Ahead
6 January 1998
Rogaine Set To Go OTC In USA
17 July 1997
FDA Year-End Approval Spate As Expected
6 January 1997
US Pharma Industry And ICH, GATT
10 June 1996
B&L Joins Legal Wrangle Over Minoxidil
6 May 1996
Z-Day: Zantac 75 Goes OTC In The USA
29 April 1996
P&U Gets Restraining Order In Rogaine Case
22 April 1996
Generic Minoxidil Follows Hard On OTC Switch
15 April 1996
Pharmacia & Upjohn First Combined Results
26 February 1996
OTC Rogaine in USA
19 February 1996
OTC Rogaine Backed In USA
27 November 1995
Directing The $250M US DTC Rx Drug Ad Spend
30 October 1995
Upjohn's Regaine as OTC
11 September 1995
Correction: Upjohn's Minoxidil In Impotence
14 August 1995
USA "No Longer Leads The World In OTCs"
8 May 1995
Two More Launches For Upjohn's Freedox
24 April 1995
UK POM-To-P Switches At End-1993
2 January 1995
FDA Balks At OTC-Switch Approvals; Blow To Makers
8 August 1994
GLAXO CLOSER TO OTC RANITIDINE
11 July 1994
UPJOHN OUTLINES STRATEGIC DIRECTIONS
18 April 1994
FIRST APPROVAL FOR UPJOHN'S CAVERJECT
21 February 1994
CURRENCY AND CHARGES IMPACT 1993 US RESULTS
7 February 1994
ROGAINE STIMULATES ERECTION BUT CAN LEAD TO PRIAPISM
7 February 1994
NIZORAL TOPS SKIN DRUG LEAGUE IN 1992
10 January 1994
UPJOHN TERMINATES LICENSE AGREEMENT
6 December 1993
SMITHKLINE BEECHAM GIVING TAGAMET REBATES
15 November 1993
UPJOHN ANTI-HIV AGENTS IN PHASE II TRIALS
5 April 1993
TAISHO FILES NDA'S
5 October 1992
FREEZES AT UPJOHN IN STRATEGY REVIEW
8 June 1992
ASTRA'S PLENDIL HEADING FOR CHF INDICATION
25 May 1992
OTHER USES FOR MERCK'S PROSCAR
18 May 1992
UPJOHN'S GLYNASE APPROVED IN USA
27 April 1992
GOOD SALES GROWTH FOR MAJOR US COS IN 1st QTR
27 April 1992
UPJOHN UPDATES ON R&D PROGRESS
13 April 1992
Showing 1-99 of 99 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- SciClone gains China rights to Zensun's Neucardin
